Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07004387Not yet recruiting
Open-label trial of aminoven in acute kidney injury (AKI) (2 arms), sponsored by Hospital Dr. Sótero del Río. Primary endpoints: Occurrence of acute kidney injury according to KDIGO criteria at 10 days and Initiation and duration of renal replacement therapy at 10 days. Planned start May 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07004387.